Immunotherapy for breast cancer in Spain: Our Best Clinics and Costs 2024

Dr. Prat is a clinical scientist with a longstanding research interest in the clinical application of laboratory findings in breast cancer, with a particular interest in gene expression and the clinical implications of different intrinsic molecular subtypes of breast cancer and also he designs and leads clinical trials of novel drugs and approaches at SOLTI, a Spanish breast cancer cooperative group. Formation MD degree in 2003 from the University of Barcelona. medical oncology fellowship in 2008 at Vall d´Hebron Institute of Oncology (VHIO). postdoctoral research associate at the Lineberger Comprehensive Cancer Center (University of North Carolina at Chapel Hill, USA) in the Laboratory of Prof. Charles M. Perou, in 2008. Track Head of the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at August Pi i Sunyer Biomedical Research Institute (IDIBAPS). President of the Board of Directors of SOLTI. member of the Executive Committee of The Breast International Group (BIG) in 2018. co-founder of the spin-off called Reveal Genomics, SL. holds three issued patents, which certificates a stable scientific career. Head of the Translational Genomics Group at VHIO (2012). Hospital Clínic and IDIBAPS (2014). Publications Part of more than 160 publications (H-Index Score of 51), with a total of 13.479 citations and 95 communications in international conferences. Teaching Tenure-Track Professor of Barcelona University (UB) Director, Breast Pathology – Senology Master´s degree, UB.

Dr. Joan Albanell Mestres is an experienced oncologist in Spain and internationally recognized for his successful breast cancer treatment. He has a vast experience in the field of medicine along with extensive research and educational background. His key takeaways include: MBBS from University Autónoma de Barcelona in 1989 Residency period at clinic Vall d'Hebron between for 3 years after 1989 Research on telomerase in New York Leading specialist and head of breast cancer program at HM Delfos Spain Leader of Oncology services at Clin del Mar of Spain Director of cancer research program at Del Mar Leading member of GEICAM, CIBERONC, AIECA, SEOM Groundbreaking researches in the field of oncology 120 articles published in reputable journals More than 9000 citations

Dr. Agusti Barnadas Molins is a distinguished Medical Oncologist with a specialty in breast cancer treatment. He's experienced in conducting Chemotherapy, Gland therapy for breast cancer, and Immunotherapy for breast cancer. He's a well-regarded researcher and educator, and he has held several esteemed positions in medical societies.Awards Dr. Barnadas Molins has been recognized with awards and grants for his research work.MembershipHe is a member of the Catalan-Balearic Oncology Society, the Spanish Medical Oncology Society (SEOM), the European Society for Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO).He is a founding member and Vice President of the Spanish Breast Cancer Research Group (GEICAM).EducationHe completed his degree in Medicine and Surgery in 1981 at the Autonomous University of Barcelona.He trained in the specialty of Medical Oncology at the Hospital de la Santa Creu i Sant Pau in Barcelona.He obtained the European Certificate in Medical Oncology in London in 1989.He holds a Ph.D. from the Universitat de Barcelona, awarded in 1991.